Oct 4, 2017 08:00AM

Oct 3, 2017 08:45AM

Oct 3, 2017 08:01AM

Oct 3, 2017 08:00AM

Sep 26, 2017 08:31AM

Sep 26, 2017 08:30AM

Sep 21, 2017 03:59PM Express Scripts (ESRX) CMO Issues Blog on CAR-Ts and Gene Therapies

Aug 30, 2017 10:50AM

Aug 28, 2017 07:01AM

Aug 28, 2017 07:00AM

Aug 8, 2017 08:00AM

Aug 8, 2017 07:47AM

Aug 8, 2017 07:45AM

Aug 7, 2017 08:30AM Kite Pharma (KITE) Initiates Axicabtagene Ciloleucel CAR-T Clinical Program in EU

Aug 7, 2017 08:30AM

Aug 2, 2017 08:36AM

Aug 2, 2017 08:30AM

Jul 31, 2017 08:34AM

Jul 31, 2017 08:30AM

Jul 13, 2017 06:20AM

Jul 12, 2017 03:31PM FDA panel backs Novartis' pioneering new cancer gene therapy

Jul 12, 2017 03:27PM

Jun 28, 2017 08:33AM

Jun 28, 2017 08:30AM

Jun 27, 2017 09:30AM

Jun 14, 2017 09:05AM

Jun 14, 2017 08:00AM

Jun 5, 2017 09:01AM Kite Pharma (KITE) Says 73% of Patients Achieved MRD Negative Complete Remission in Updated Analysis From Phase 1 ZUMA-3 CAR-T Trial of KTE-C19 in Adult Patients With High Burden R/R ALL

Jun 5, 2017 09:00AM

May 26, 2017 10:47AM

May 26, 2017 10:47AM

May 17, 2017 05:06PM

May 17, 2017 05:05PM

May 8, 2017 08:00AM

Apr 6, 2017 08:30AM Kite Wins ‘Clinical Trial Result of the Year’ for its Pivotal CAR-T Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma at the 2017 Clinical and Research Excellence A

Apr 3, 2017 09:29AM

Apr 3, 2017 06:37AM

Apr 2, 2017 04:04PM

Mar 31, 2017 03:16PM

Mar 31, 2017 03:15PM

Mar 30, 2017 08:32AM

Mar 30, 2017 08:30AM Kite to Present Two Plenary Presentations from the ZUMA-1 Pivotal Trial of Axicabtagene Ciloleucel at the 2017 American Association of Cancer Research Annual Meeting

Mar 15, 2017 10:12AM

Mar 6, 2017 08:30AM

Mar 6, 2017 07:06AM

Feb 28, 2017 08:00AM

Feb 28, 2017 07:03AM

Feb 28, 2017 07:00AM

Jan 24, 2017 07:06AM Kite Pharma (KITE): FDA Likely To Evaluate ZUMA-1 In Two Cohorts - Jefferies

Jan 10, 2017 09:23AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All